Albumin, Iodinated I 131 Serum

CHEMBL1201453 Phase 4 Onaylandı Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A radioactively labeled albumin preparation using iodine-131, historically used to measure blood volume, cardiac output, and diagnose protein-losing conditions. The iodine-131 label emits detectable gamma radiation that allows clinicians and researchers to track the protein's movement through the circulation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A radioactively labeled albumin preparation using iodine-131, historically used to measure blood volume, cardiac output, and diagnose protein-losing conditions. The iodine-131 label emits detectable gamma radiation that allows clinicians and researchers to track the protein's movement through the circulation.

Yes, Albumin, Iodinated I 131 Serum is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201453. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Albumin, Iodinated I 131 Serum PillFYI'da

Hızlı Veriler

Dış Bağlantılar

ChEMBL CHEMBL1201453

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.